NCT05685862View on ClinicalTrials.gov

Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastric Conduit

UnknownOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

May 31, 2024

Conditions
Oesophageal Cancer
Interventions
DEVICE

Laser Speckle Contrast Imaging using the PerfusiX-Imaging device

Patient will undergo the standard-of-care gastric conduit procedure and in addition, peroperative Laser Speckle Contrast Imaging of the gastric conduit and eosophagus will be performed.

Trial Locations (1)

8934 AD

RECRUITING

Medical Center Leeuwarden, Leeuwarden

Sponsors

Collaborators (1)

LIMIS Development
All Listed Sponsors
collaborator

University of Groningen

OTHER

collaborator

LIMIS Development

UNKNOWN

lead

Frisius Medisch Centrum

OTHER

NCT05685862 - Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastric Conduit | Biotech Hunter | Biotech Hunter